Inspection Record

Altea Farmaceutica SA — Health Canada Inspection Findings

Health CanadaInspected 2023-09-11 5 findingsEquipment and facilityCleaning validationLaboratory and QC controlsMaterial and supplier control

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

The receipt, preparation, and/or handling of reagents and culture media was inadequate. The establishment and/or the maintenance of a data governance plan was inadequate.

2Cleaning validation

The implementation, effectiveness, and/or validation of the cleaning procedures was inadequate for preventing unsanitary conditions.

3Equipment and facility

The preventative maintenance program was inadequate for the equipment used in significant processing and/or testing operations.

4Laboratory and QC controls

The establishment and/or the maintenance of a data governance plan was inadequate. The creation, maintenance, processing, and/or review of laboratory data was inadequate.

5Material and supplier control

The sampling plan for raw materials was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2023-09-11. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Altea Farmaceutica SA company profile — full history Health Canada documents, 2023 Go to Findings search